We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

FENG:NYSEPhoenix New Media Limited Analysis

Data as of 2026-04-02 - not real-time

$1.76

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

Phoenix New Media trades around $1.76, just above the computed support of $1.72 and well below the 200‑day SMA of $2.13, indicating a short‑term price cushion but a long‑term downtrend. Technical signals are mixed: the 20‑day SMA sits slightly above the 50‑day SMA, RSI is neutral at 45, while the MACD histogram is negative, flagging bearish momentum. Fundamentally, the company posted a modest Q4 profit of $6.5 million (≈$0.54 EPS) and a 1.9% YoY revenue increase, yet margins remain thin with a profit margin of 0.04%. The balance sheet is strong, boasting over $1 billion in cash against $43 million of debt, resulting in a net cash position that dwarfs liabilities. Valuation metrics are strikingly low – a forward P/E of 2.59 versus an industry average of 17.34, a price‑to‑book of 0.12 and a price‑to‑sales of 0.028 – suggesting the stock is deeply undervalued. However, the stock’s beta of ~0.43, 30‑day volatility of 33%, and a market cap of just $21 million with thin trading volumes raise liquidity and market‑risk concerns, while the Chinese internet sector faces heightened regulatory scrutiny.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 5/10

Key Factors

  • Price hovering just above the $1.72 support level
  • Bearish MACD histogram and neutral RSI
  • Thin daily volume and high liquidity risk

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • Extremely low forward P/E (2.59) vs industry average
  • Strong net cash position exceeding debt by >$950 million
  • Recent profit beat and modest revenue growth

Long Term

> 3 years
Neutral
Model confidence: 5/10

Key Factors

  • Persistent regulatory risk in China's internet content space
  • Limited long‑term growth prospects and thin margins
  • Valuation cushion provides downside protection despite volatility

Key Metrics & Analysis

Financial Health

Revenue Growth1.90%
Profit Margin0.04%
P/E Ratio2.6
ROE0.03%
ROA-1.28%
Debt/Equity3.91
P/B Ratio0.1
Industry P/E17.3

Technical Analysis

TrendNeutral
RSI45.0
Support$1.72
Resistance$1.95
MA 20$1.81
MA 50$1.79
MA 200$2.13
MACDBearish
VolumeIncreasing
Fear & Greed Index78.8

Valuation

GradeUndervalued
TypeValue

Risk Assessment

Beta0.43
Volatility32.86%
Sector RiskMedium
Reg. RiskHigh
Geo RiskMedium
Currency RiskMedium
Liquidity RiskHigh

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.